ArticleJournal of cannabis research2025

Preclinical assessment of pharmacokinetics and anticonvulsant activity of CBDTech, a novel orally administered cannabidiol (CBD) formulation for seizure and epilepsy.

Jacob D McDonald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.